Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Looking4Doubleson Jun 17, 2020 10:26am
95 Views
Post# 31159731

RE:RE:There’s not even a vote re salzman purchase that will wipe r

RE:RE:There’s not even a vote re salzman purchase that will wipe r
Jack4000 wrote:

Ed is wrong yet again.  On all poinbts - quite the feat in this day and age of information at ones fingertips.
 

edrose wrote: Out retail investors 

 

Did you sell our shares Edly?

If not then you are not outed.  If so then you are outed and, you did it all yourself - not Salzman.

 

edrose wrote: ,salzman will own 49% of kly   Then we must pay salzman 29 million dollars plus 5 million  paid in shares. Resulting in salzman owning the vast majority of kly 

 

Only if they meet all the benchmarks which, would mean that we are rich because of their hard work and efforts in meeting the CILI, COVID and PAH requirments to develop lifesaving drugs and therapies.

Ed, it's what we do, you know, develop stuff that saves lives and make money for doing it.

If they don't make those drugs or therapies then we pay them nothing more so you are wrong.

 

edrose wrote:
barda funding  zero guarantees  

 

I highly doubt BARDA will chose this time and place to cut off funding to the CILI development after all these years - nor do I expect them to refuse funding for COVID
- after asking us to apply and;
- given the fact they are throwing money at everybody and everything like a drunken sailor and;
- given our history with them they are more likely to give funding to another related project in time of pandemic than not
 

edrose wrote:
kly doesn't have money to do research on r107  

 

BARDA funded dude.  In face we make a profit after paying out the research bills.

 

edrose wrote:  and we can't even finish our phase3 study which would give us product bringing in min 400 million/yr 

 

We can though - once we get $18 million dollars.  The billions of dollars of potential profit that the other treatments that Salzman brings to the table would enable us to continue with GVHD easily Ed.

 

edrose wrote:
shy did ceo and board stop dev our product by finding partner 

 

We were short $18 million to develop it.  Golly Ed, brush up on current events sometime.

 

edrose wrote:
why don't they give us update re 5 million pp. how much money did they raise 

 

They have yet to announce it as open Ed.  Once they do and a couple of weeks to a month passes then they probably will announce how it is going or, when it is closed.
 



Nicely said Jack, but don't expect Ed or our troll to acknowledge anything.  They are heavily invested in the opposing view.
<< Previous
Bullboard Posts
Next >>